Show simple item record

dc.contributor.authorLuo, Yi
dc.contributor.authorFeng, Yu
dc.contributor.authorSong, Lei
dc.contributor.authorHe, Gan-Qing
dc.contributor.authorLi, Sha
dc.contributor.authorBai, Sha-Sha
dc.contributor.authorHuang, Yu-Jie
dc.contributor.authorLi, Si-Ying
dc.contributor.authorAlmutairi, Mohammed M.
dc.contributor.authorShi, Hong-Lian
dc.contributor.authorWang, Qi
dc.contributor.authorHong, Ming
dc.identifier.citationLuo, Y., Feng, Y., Song, L., He, G. Q., Li, S., Bai, S. S., Huang, Y. J., Li, S. Y., Almutairi, M. M., Shi, H. L., Wang, Q., & Hong, M. (2019). A network pharmacology-based study on the anti-hepatoma effect of Radix Salviae Miltiorrhizae. Chinese medicine, 14, 27.
dc.descriptionThis work is licensed under a Creative Commons Attribution 4.0 International License.en_US
dc.description.abstractBackground Radix Salviae Miltiorrhizae (RSM), a well-known traditional Chinese medicine, has been shown to inhibit tumorigenesis in various human cancers. However, the anticancer effects of RSM on human hepatocellular carcinoma (HCC) and the underlying mechanisms of action remain to be fully elucidated.

Methods In this study, we aimed to elucidate the underlying molecular mechanisms of RSM in the treatment of HCC using a network pharmacology approach. In vivo and in vitro experiments were also performed to validate the therapeutic effects of RSM on HCC.

Results In total, 62 active compounds from RSM and 72 HCC-related targets were identified through network pharmacological analysis. RSM was found to play a critical role in HCC via multiple targets and pathways, especially the EGFR and PI3K/AKT signaling pathways. In addition, RSM was found to suppress HCC cell proliferation, and impair cancer cell migration and invasion in vitro. Flow cytometry analysis revealed that RSM induced cell cycle G2/M arrest and apoptosis, and western blot analysis showed that RSM up-regulated the expression of BAX and down-regulated the expression of Bcl-2 in MHCC97-H and HepG2 cells. Furthermore, RSM administration down-regulated the expression of EGFR, PI3K, and p-AKT proteins, whereas the total AKT level was not altered. Finally, the results of our in vivo experiments confirmed the therapeutic effects of RSM on HCC in nude mice.

Conclusions We provide an integrative network pharmacology approach, in combination with in vitro and in vivo experiments, to illustrate the underlying therapeutic mechanisms of RSM action on HCC.
dc.description.sponsorshipGuangzhou Science Technologyen_US
dc.description.sponsorshipInnovation Commission Technology Research Projects (No. 201805010005)en_US
dc.rights© The Author(s) 2019.en_US
dc.subjectRadix Salviae Miltiorrhizaeen_US
dc.subjectHepatocellular carcinomaen_US
dc.subjectNetwork pharmacologyen_US
dc.titleA network pharmacology-based study on the anti-hepatoma effect of Radix Salviae Miltiorrhizaeen_US
kusw.kuauthorLi, Si-Ying
kusw.kuauthorAlmutairi, Mohammed M.
kusw.kuauthorShi, Hong-Lian
kusw.kudepartmentPharmacology & Toxicologyen_US
kusw.oanotesPer Sherpa Romeo 11/17/2020:

Chinese Medicine [Open panel below]Publication Information TitleChinese Medicine [English] ISSNsElectronic: 1749-8546 URL Publishers BMC [Commercial Publisher] International Society for Chinese Medicine [Associate Organisation] DOAJ Listing Requires APCYes [Data provided by DOAJ] [Open panel below]Publisher Policy Open Access pathways permitted by this journal's policy are listed below by article version. Click on a pathway for a more detailed view.

Published Version NoneCC BYPMC Any Website, Journal Website, +3 OA PublishingThis pathway includes Open Access publishing EmbargoNo Embargo LicenceCC BY Copyright OwnerAuthors Publisher Deposit PubMed Central Europe PubMed Central Location Any Website Author's Homepage Institutional Repository Named Repository (PubMed Central) Journal Website Conditions Copy of License must accompany any deposit. Published source must be acknowledged Must link to publisher version with DOI
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2019.
Except where otherwise noted, this item's license is described as: © The Author(s) 2019.